Contents of Serum P-selectin As An Early Marker of Endothelium Dysfunction and Atherosclerotic Changes in Patients with Chronic Kidney Disease
DOI:
https://doi.org/10.61841/gryba289Keywords:
Chronic Kidney Disease, Endothelial Dysfunction, P-selectin, Blood SerumAbstract
Objective: to study the content of P-selectin in the blood of patients with chronic kidney disease (CKD) and evaluate its effect on the development of endothelial dysfunction (ED) and atherosclerotic changes.
Material and methods: In 65 patients with CKD (average age 61.2 ± 1.7 years), the level of P-selectin in the blood serum was determined. The control group consisted of 20 relatively healthy individuals without CKD, comparable in age and sex with the study group. All patients analyzed the data of clinical, laboratory, and instrumental methods of research. The diagnosis of CKD was made in accordance with the recommendations of KDIGO (2012) and ICD-10. The content of P-selectin in the selected and frozen blood sera of patients was determined by the method of enzyme-linked immunosorbent assay.
Results. With CKD, a violation of immune homeostasis associated with clinical manifestations was revealed, characterized by significantly higher serum P-selectin values. However, when it is increased, the concentration of P-selectin in the blood depends on the stage and category of CKD: as GFR decreases (59 ml/min/1.73 m² or less), the serum level of P-selectin significantly decreases, especially with CKD stage III-V. In patients with CKD with clinical, laboratory, and instrumental signs of ED and atherosclerosis, the level of P-selectin increases more significantly compared with patients with CKD without atherosclerotic changes. There is a close relationship between the level of P-selectin and various clinical and biochemical syndromes of kidney pathology. As the inflammatory process, hypercholesterolemia, urinary and nephrotic syndromes, as well as arterial hypertension syndrome, the concentration of P-selectin increases. However, with uremia and hypercreatininemia, serum P-selectin levels decrease.
Conclusions. The established abnormalities are based on the inflammatory process in the kidneys and activation/dysfunction of the endothelium and platelets. The deepening imbalance of the mediator of intercellular interactions of P-selectin with the progression of CKD (up to the terminal stage) and the presence of a relationship with various clinical options for renal pathology are evidence of the important clinical and pathogenetic significance of selectin disorders in the progression of the process and the formation of atherosclerotic changes and other complications of CKD.
Downloads
References
[1] Bedelbaeva G.G., Mukhambetyarova S.A., Nurmakhanova Zh.M. Features of the course of myocardial
infarction in patients with type 2 diabetes mellitus // Clinical medicine of Kazakhstan. - 2013. - No. 3 (29).
- S. 16-20.
[2] Belokopytova IS, Moskalets OV, Paleev FN, Zotova OV The diagnostic value of adhesion molecules
sICAM-1 and sVCAM-1 in coronary heart disease // Atherosclerosis and dyslipidemia. - 2013. - No. 4 (12).
- S. 62-65.
[3] Gilyazova G.I., Koroy P.V. Selectins in chronic liver disease // Bulletin of a young scientist. - 2013. - No.
1. - S. 14-18.
[4] Gilyazova G.I., Koroy P.V., Yagoda A.V. Selectins as predictors of the adverse course of liver cirrhosis //
Medical Bulletin of the North Caucasus. - 2013. - No. 2. - S. 80-81.
[5] Gilyazova G.I., Mukhoramova I.S., Rudenko Yu.A., Koroy P.V. The role of adhesion molecules in the
immune response // Bulletin of a young scientist. - 2012. - No. 2. - S. 21-27.
[6] Ivanov A.N., Norkin I.A., Puchinyan D.M. and other Adhesive molecules of the endothelium of the
vascular wall // Uspekhi Fiziologicheskikh Nauk. - 2014. - T. 45, No. 4. - S. 34-49.
[7] Komelkova L.V., Ionova V.G. Adhesion molecules and platelet-vascular hemostasis in patients with
stenosis of the internal carotid artery of atherosclerotic origin // Thrombosis, hemostasis and rheology.
2011. - No. 1. - S. 53-60.
[8] Maksimova M.Yu., Komelkova L.V., Okhtova F.R. Factors of intercellular interaction in ischemic stroke //
Zh. nevrol. and a psychiatrist. - 2014. - No. 2. - S. 15-20.
[9] Morozov Yu.A., Marchenko T.V. Chronic kidney disease and hemostatic disorders // Hemorrhagic
diathesis, thrombosis, thrombophilia. - 2014. - No. 1.
[10] Petri A., Sabin K. Visual medical statistics: a training manual / Per. from English ed. V.P. Leonov. - 2nd
ed., Revised and add. - M., GEOTAR-Media, 2010.--169 p.
[11] Rasulova H.A., Ikramova A.Sh. The use of anticoagulants in patients with chronic renal failure // Internat.
Scientific Journal Global Science and Innovations 2019: Central Asia. - Nur-Sultan, Kazakhstan, Sept.-
Oct., 2019.--P. 167-171.
[12] Rasulova H.A., Nishonov Sh.Yu., Abbasov A.K., Khusinbaev I.D. Fluctuations in blood pressure in
patients with ischemic stroke, depending on the pathogenetic subtypes and functional state of the kidneys //
Neurology- Mat. conf. "Current issues in the diagnosis and treatment of neurological diseases." -
Tashkent, December 6, 2019. - No. 4 (80). - S. 174.
[13] Romaniuk S.V. Lymphocyte-platelet adhesion and sP-Selectin level in patients with myocardial infarction
// Symbol of science. - 2017 .-- Vol. 2, No. 1. - R. 174-177.
[14] Sigitova O.N. Chronic kidney disease: current status of the issue // Diary of Kazan Medical School. - 2013.
- No. 1 (1). - S. 59-62.
[15] Smirnov A.V., Dobronravov V.A., Kayukov I.G. The problem of modifying the classification of chronic
Kidney disease // Nephrology. - 2010. - No. 15 (2). - S. 7-15.
[16] Umarova Z.F., Rasulova H.A. Modern approaches to predicting complications of coronary heart disease //Electron. periodic peer-reviewed scientific journal "SCI-ARTICLE.RU." - 2020. - No. 77 (January). - S. 73-78.
[17] Khaitov P.M., Ignatieva G.A., Sidorovich I.G. Immunology. Norm and pathology.—The textbook.—3rd ed., revised and added. - M.: Publishing House "Medicine," 2010. - 752 p.
[18] Chepel E., Haney M., Misbach S., Snovden N. Fundamentals of clinical immunology. - Translation from English. - 5th ed. - M.: GEOTAR-Media, 2008.--416 p.
[19] Chizhova M.A., Hammad E.V., Mursalov S.U., Sedova E.V. Studying the levels of signaling molecules in blood serum with coronary heart disease, iron deficiency anemia, and their combination in elderly patients // Modern problems of science and education. - 2015. - No. 6.
[20] Berry A.V., Koroy P.V., Gilyazova G.I. Selectins as predictors of stable virological clearance in chronic
viral hepatitis C // Medical Bulletin of the North Caucasus. - 2013. - No. 3. - S. 5-9.
[21] Berry A.V., Koroy P.V., Gilyazova G.I. Selections and histological picture in chronic viral diseases of the
liver // Medical Herald of the North Caucasus. - 2013. - No. 1. - S. 29-33.
[22] Abbasov A.K., Rasulova Kh.A. Modern data on modifiable and non-modifiable risk factors of chronic
kidney disease // Internat. Scientific Journal Global Science and Innovations 2019: Central Asia. - Nur-Sultan, Kazakhstan, Sept.-Oct., 2019 . -- P. 67-70.
[23] Abbasov A.K., Rasulova Kh.A. Changes in lipid metabolism in patients with chronic kidney disease // XIII
International Symposium on the Chemistry of Natural Compounds (ISCNC 2019). - Shanghai, China,
October 16-19, 2019.--P. 40.
[24] Abbasov A.K., Rasulova Kh.A. The role of P-selectin in development and progression of chronic kidney
disease // Bulletin of TMA. - Tashkent, 2019.-- No. 4. - S. 181-183.
[25] Arbel Y., Halkin A., Finkelstein A., Revivo M., Berliner S., Herz I., Keren G., Banai S. Impact of
estimated glomerular filtration rate on vascular disease extent and adverse cardiovascular events in patients
without chronic kidney disease // J. Cardiol. - 2013 .-- Vol. 29 (11). - R. 1374–1381.
[26] Daminov B.T., Abdullaev Sh.S. Left Ventricular Structure during Antihypertensive Treatment in Patients
with Chronic Kidney Disease // International Journal of Biomedicine. - 2016.
[27] Daminov B.T., Ubaydullaeva B.N. Anemia in patients receiving programmed hemodialysis // Central
Asian J. Pediatrics. - 2019 .-- Vol. 2 (11) -- P. 131-141.
[28] Dimastromatteo J., Broisat A., Perret P. et al. In vivo molecular imaging of atherosclerotic lesions in ApoE
- / - mice using VCAM-1-specific, 99mTc-labeled peptidic sequences // J. Nucl. Med. - 2013. - V. 54, No.
8. - R. 1442-1449.
[29] Glowinska B., Urban M., Peczynska J., Florys B. Soluble adhesion molecules (sICAM-1, sVCAM-1) and
selectin (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension
and diabetes // Metabolism. - 2005. - V. 54, No. 8. - R. 1020-1026.
[30] Horikawa M., Fujimoto M., Hasegawa M. et al. E- and P-selectins synergistically inhibit bleomycin-induced pulmonary fibrosis // Am. J. Pathol. 2006. - Vol. 169, No. 3. - P. 740-749.
[31] Hwang S.J., Ballantyne C.B., Sharrett A.R. et al. Circulating adhesion molecules VCAM-1, ICAM-1, and
E-selectin in carotid atherosclerosis and incidental coronary heart disease cases. The Atherosclerosis risk in
communities (ARIC) study // Circulation. - 1997. - Vol. 96. - R. 4219-4225. PMID: 9416885.
[32] KDIGO, 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
// Kidney Int (Suppl.).—2013.—Vol. 3.—R. 1–150.
[33] Ling S., Nheu L., Komesaroff P.A. Cell adhesion molecules as pharmaceutical target in atherosclerosis //
Mini. Rev. Med. Chem. - 2012. - V. 12, No. 2. - P. 175-183.
[34] Monson K.M., Dowlatshahi S., Crockett E.T. CXC-chemokine regulation and neutrophil trafficking in
hepatic ischemia-reperfusion injury in P-selectin/ICAM-1-deficient mice // J. Inflamm. - 2007. - Vol. 24. -
P.4-11.
[35] Rasulova Kh.A., Abbasov A.K. P-selectin is a new marker of endothelial dysfunction // Neurology. - Mat.
conf. "Current issues in the diagnosis and treatment of neurological diseases." - Tashkent, December 6,
2019.-. 4 (80).—S. 132.
[36] Smith C.W. Adhesion molecules and receptors // J. Allergy. Clin. Immunol. - 2008. - V. 121, No. 2. - R.
S375-S379.
[37] Sumagin R., Kuebel J.M., Sarelius I.H. Leukocyte rolling and adhesion both contribute to regulation of microvascular permeability to albumin via ligation of ICAM-1 // Am. J. Physiol. Cell. Physiol. - 2011. - V.301, No. 4. - R. C804-C813.
[38] Van der Velde M., Matsushita K., Coresh J., et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk populations cohorts // Kidney Int. - 2011. - Vol. 79 (12). - P. 1341-1352.
[39] Yoshizaki A., Yanaba K., Iwata Y. et al. Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model // J. Immunol. - 2010 .-- Vol. 185, No. 4. - P. 2502-2515.
[40] Yu Z., Otsuka H., Yamaguchi K. et al. Roles of platelets and macrophages in the protective effects of lipopolysaccharide against concanavahn A-induced murine hepatitis // Biochim. Biophys. Acta. - 2011. - Vol. 1812, No. 9. - P. 1069-1079.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
